SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending with significant community buzz, fueled by a recent positive analyst rating and high short interest, igniting speculation of a potential squeeze. Investors are keenly anticipating announcements from the ongoing J.P. Morgan Healthcare Conference regarding new partnerships, strategic updates, and the broader application of its Matrix-M platform. Underlying this activity, discussions persist about management's performance amidst calls for a buyout to unlock the company's perceived intrinsic value.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending due to impressive preliminary fourth-quarter revenue growth, signaling strong demand from defense and government sectors. Community conversations are buzzing with speculation about the company's Black Widow drones being deployed in recent military operations and high anticipation for potential large orders from the upcoming 'Gauntlet' program. This positions RCAT as a key player in the expanding U.S. drone market, driven by increased defense spending and initiatives for domestic production.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath (PATH) is gaining significant attention for its strategic pivot to Agentic AI orchestration and recent inclusion in the S&P MidCap 400. Investors are actively debating the stock's volatility, often attributed to perceived manipulation and insider selling, while many view current price levels as a prime opportunity to accumulate shares, anticipating substantial long-term growth as a pure-play leader in the AI space.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is experiencing a surge in attention following a significant analyst upgrade, driven by strong hyperscaler demand for its server CPUs and positive developments in its foundry business, including improved 18A yields and potential new client discussions. The community is actively discussing a potential short squeeze and the stock's undervaluation, further fueled by Intel's strategic advancements in chip manufacturing and perceived government backing for domestic semiconductor production.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is trending amid a mixed market reaction to its latest earnings, where strong financial results and robust future guidance are being overshadowed by a wave of analyst downgrades citing intensified AI competition. The community is sharply divided, with frustrated long-term investors questioning the market's bearish narrative and perceived manipulation, while others view the current valuation as a compelling buying opportunity for a fundamentally sound company actively leveraging AI and executing significant share buybacks.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is a major talking point following a Goldman Sachs downgrade to 'Sell' with a $26 price target, which many investors interpret as a deliberate move to manipulate the stock lower ahead of strong earnings. The community remains highly divided, with bulls highlighting SMCI's essential role in the booming AI infrastructure and significant revenue growth, while skeptics point to ongoing profitability concerns and past accounting issues that have weighed on sentiment.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is actively trending following global regulatory submissions for its seasonal flu vaccine and significant funding for a pivotal pandemic influenza vaccine trial, alongside a positive European recommendation for its next-generation COVID-19 vaccine. The community is buzzing about the stock's robust rebound from multi-year lows, with many anticipating a potential short squeeze and significant long-term upside driven by its promising oncology pipeline, particularly the personalized cancer vaccine partnership with Merck. Investors are emphasizing the company's strong cash position and perceived undervaluation as it evolves into a diversified mRNA platform beyond its initial success.

Ambitions Enterprise Management Co. LLC operates as a travel agency. It provides event planning and management services. The firm also offers transportation, accommodations, meals, and guided tours or activities under convenient packages. The company was founded on October 26, 2023 and is headquartered in Dubai, United Arab Emirates.

Ambitions Enterprise Management Co LLC - Ordinary Shares - Class A

Ambitions Enterprise Management Co LLC

Ambitions Enterprise Management (AHMA) is experiencing intense trading activity, largely driven by its extremely low float and community speculation about a significant short squeeze. Investors are actively discussing breaking key resistance levels and setting ambitious price targets, often comparing its current trajectory to other recent volatile low-float runners.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is actively trending due to significant strategic shifts, including plans to double production of its AI smart glasses and the new "Meta Compute" initiative focused on a massive AI infrastructure buildout with nuclear energy partnerships. While some investors see the renewed focus on AI and recent Reality Labs layoffs as a bullish pivot towards efficiency and future growth, others express caution regarding the substantial long-term spending and its impact on profitability, fueling a polarized community debate.

Visa, Inc. engages in the provision of digital payment services. It also facilitates global commerce through the transfer of value and information among a global network of consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It offers debit cards, credit cards, prepaid products, commercial payment solutions, and global automated teller machines. The company was founded by Dee Hock in 1958 and is headquartered in San Francisco, CA.

Visa Inc - Ordinary Shares - Class A

Visa Inc

Visa is trending amid market volatility sparked by political rhetoric regarding a proposed cap on credit card interest rates and the Credit Card Competition Act. The community is divided, with many debating whether these regulatory threats will significantly impact Visa's transaction-fee model or are merely noise, presenting a buying opportunity for some investors. Meanwhile, Visa continues to advance its digital payment initiatives, including integrations with stablecoins.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Karyopharm Therapeutics (NASDAQ:KPTI) Stock Crosses Above Fifty Day Moving Average - What's Next?

Karyopharm Therapeutics (NASDAQ:KPTI) Shares Cross Above Fifty Day Moving Average - Here's What Happened...

Karyopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026

Karyopharm Announces Preliminary Unaudited 2025 Revenue and Reiterates Expectation of Delivering Potentially Transformative Phase 3 Data in 2026 Karyopharm Announces Preliminary Unaudited 2025...

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire NEWTON...

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the six brokerages that are currently covering the firm...

Nuclear Stocks To Consider - December 12th

Oklo, NuScale Power, Centrus Energy, BWX Technologies, Nano Nuclear Energy, Lightbridge, and Karyopharm Therapeutics are the seven Nuclear stocks to watch today, according to MarketBeat's stock...

Top Nuclear Stocks To Consider - December 9th

Karyopharm Therapeutics (NASDAQ:KPTI) Stock Price Passes Above 50-Day Moving Average - Here's What Happened

Karyopharm Therapeutics (NASDAQ:KPTI) Stock Price Passes Above Fifty Day Moving Average - Here's Why...

Karyopharm to Participate in Baird's Biotech Discovery Series

Karyopharm to Participate in Baird's Biotech Discovery Series Karyopharm to Participate in Baird's Biotech Discovery Series PR Newswire NEWTON, Mass., Dec. 8, 2025 NEWTON, Mass., Dec. 8, 2025...

Nuclear Stocks To Add to Your Watchlist - December 6th

Nuclear Stocks To Watch Now - December 4th

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Current Price	$7.62
Prev Close	$8.20
Open	$8.18
Dividend Yield	0.00%
50-Day Moving Average	$6.37
Beta	1.21
Avg. Volume	253,805.23
PE Ratio	-0.56

52-Week High	$10.80
52-Week Low	$3.51
Market Capitalization	$150.05M
EPS (Annual)	-$9.41
Price to Book	-0.26
Revenue Per Employee	$520,562.72
Enterprise Value/EBITDA	N/A

KPTI
Karyopharm Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest KPTI News

KPTIKaryopharm Therapeutics Inc